Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SOLIGENIX-INC-32430006/news/HyBryte-Use-in-Early-Stage-Cutaneous-T-Cell-Lymphoma-Published-in-Frontiers-in-Drug-Discovery-45482823/?utm_source=whatsapp&utm_medium=social&utm_campaign=share